
4-Br-BnIm
CAS No. 1654775-71-9
4-Br-BnIm ( —— )
产品货号. M12525 CAS No. 1654775-71-9
一种有效的亚型选择性 Grp94 抑制剂,Kd 为 0.96 uM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称4-Br-BnIm
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述一种有效的亚型选择性 Grp94 抑制剂,Kd 为 0.96 uM。
-
产品描述A potent, subtype-selective Grp94 inhibitor with Kd of 0.96 uM, 13-fold selectivity over Hsp90α; facilitates mutant myocilin degradation and rescues phenotypes in a transgenic mouse model of hereditary primary open-angle glaucoma.
-
体外实验Cell Viability Assay Cell Line:Primary human HTM cells.Concentration:30 μM.Incubation Time:24 h.Result:Significantly reduced the level of Y437H mutant myocilin without affecting WT myocilin and the RFP vector in HEK cells.Western Blot Analysis Cell Line:HEK cells.Concentration:0, 1, 3, 10, 30 and 100 μM.Incubation Time:24 h.Result:Significantly decreased 1477N mutant myocilin in HEK cells expression without causing the degradation of other Hsp90-dependent clients Akt and Ras.
-
体内实验Animal Model:Tg-MYOCY437Hmice.Dosage:300 μM.Administration:Eye drops; once daily for 12 weeks.Result:Inhibited mutant myocilin expression and restored the PhNR deficits.
-
同义词——
-
通路Cytoskeleton/Cell Adhesion Molecules
-
靶点HSP
-
受体HSP
-
研究领域——
-
适应症——
化学信息
-
CAS Number1654775-71-9
-
分子量465.728
-
分子式C20H18BrClN2O4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 33.33 mg/mL (71.57 mM)
-
SMILES——
-
化学全称methyl 2-(2-(1-(4-bromobenzyl)-1H-imidazol-2-yl)ethyl)-3-chloro-4,6-dihydroxybenzoate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Stothert AR, et al. Sci Rep. 2017 Dec 20;7(1):17951.
2. Crowley VM, et al. J Med Chem. 2016 Apr 14;59(7):3471-88.